Ebit Zmiana Data
AbbVie USD 4.52B 378M 2023-09
Aceragen USD -7443000 1.14M 2023-03
Adma Biologics USD 14.23M 5.55M 2023-12
Amgen USD 1.8B 254M 2023-12
AstraZeneca USD 2.15B 418M 2023-09
Biogen USD 512M 226.7M 2023-12
BioMarin Pharmaceutical USD 28.22M 2.56M 2023-12
Bristol-Myers Squibb USD 2.61B 104M 2023-12
Dynavax Technologies USD -7005000 12.01M 2023-12
Gilead Sciences USD 2.15B 475M 2023-12
Merck USD -299000000 6.8B 2023-12
Minerva Neurosciences USD -6079120 1.56M 2023-09
Nektar Therapeutics USD -33504000 541K 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -125000000 2.34B 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Sarepta Therapeutics USD -20842000 112.68M 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Dynavax Technologies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.